Baker Hughes clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Baker Hughes
BKR · a US exchange · USD · Market cap $47.4B · 53,000 employees
Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain.
Not yet scoredPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price46.67 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.21)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $45.90 to $54.25, base estimate $47.18 (screen dated 2026-11-19).
- Trend Distribution
- Insiders insiders sold, $27,228, latest filing 2026-11-13
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.21, read 2026-11-19
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Baker Hughes holds its Distribution at $46.67. The statistical read favours the sellers, held for 12 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 12 days |
| Price at the screen | $46.67 |
| Valuation | 16.42 trailing · 16.92 forward price to earnings |
| Values screen | Not scored · score 88.7 |
| Beta | 1.06 |
Five Screens: BKR's Results
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 14.89% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 22.68% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadThe Read, in Plain English
Baker Hughes clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Baker Hughes clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 15%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades at roughly a 1% discount to our $47.18 fair value, moderate competitive moat, 14.50% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 1.1% discount to the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +51% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $47.18, with a range of $45.90 to $54.25, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 16.9xfairly priced for its growth rate |
| Trailing P/E | 16.4xreasonably valued |
| EPS, trailing | 2.91 |
| EPS, forward | 2.82 |
| Revenue growth | +14.5%steady growth |
| Profit margin | 10.1%thin but positive margins |
| Return on equity | 15.1%a solid return on shareholder capital |
| FCF yield | 10.71% |
| Dividend yield | 1.94% |
| Debt to equity | 0.89moderate, manageable leverage |
| Current ratio | 1.24adequate liquidity, worth monitoring |
| Beta | 1.06moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 44.26 - 70.41 |
| Moat | MODERATE |
| Market cap | $47.4B |
| Employees | 53,000 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Top 5 Activist Target Stocks for Spin-offs or Breakups Yahoo Finance · 10d ago
- Baker Hughes Stock Outlook: Is Wall Street Bullish or Bearish? Yahoo Finance · 10d ago
- PuppyGraph Raises $10M Series A to Help Enterprises Build AI Agents That Query 3,000 Tables in Subseconds Yahoo Finance · 10d ago
- Venture Global CEO Eyes New Growth Opportunity In Off-Grid Power For AI Data Centers – Firm Raises FY2026 Guidance After Record Q3 Earnings Yahoo Finance · 10d ago
- 2 Stocks Sidestep the Data Center Backlash Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-13 | Charlton Rebecca L | SVP, Controller, CAO | S - Sale+OE | 555 | $27,228 |
| 2026-05-19 | APOSTOLIDES JAMES E | Officer | 12,261 | $814,376 | |
| 2026-03-16 | BORRAS MARIA CLAUDIA | Officer | 60,626 | $3,302,298 | |
| 2026-03-11 | SIMONELLI LORENZO | Chief Executive Officer | 272,594 | $16,025,801 | |
| 2026-03-11 | MAGNO MARIA GEORGIA | Officer | 5,063 | $298,920 | |
| 2026-03-11 | SIMONELLI LORENZO | Chief Executive Officer | 187,344 | $6,688,181 | |
| 2026-03-06 | APOSTOLIDES JAMES E | Officer | 23,739 | · | |
| 2026-03-06 | MAGNO MARIA GEORGIA | Officer | 10,665 | · | |
| 2026-03-06 | MOGHAL AHMED FARHAN | Chief Financial Officer | 29,563 | · | |
| 2026-03-06 | BORRAS MARIA CLAUDIA | Officer | 99,962 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-27 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $64.60 | -2.2% | · | $978 | -2.2% |
| 2 months | $62.62 | +0.9% | $0.23 | $1,013 | +1.3% |
| 3 months | $55.71 | +13.4% | $0.23 | $1,139 | +13.9% |
| 6 months | $47.12 | +34.1% | $0.46 | $1,351 | +35.1% |
| 1 year | $38.42 | +64.5% | $0.92 | $1,669 | +66.9% |
| 2 years | $31.17 | +102.8% | $1.80 | $2,085 | +108.5% |
| 3 years | $28.12 | +124.8% | $2.62 | $2,341 | +134.1% |
| 5 years | $22.99 | +174.9% | $4.09 | $2,927 | +192.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BKR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.